ADD/ADHD Research

Atomoxetine Ingestions in Children: A Report from Poison Centers

Henry A Spiller, Chris P Lintner, and Mark L Winter

(June) Ann Pharmacother 3 May 2005. highwire.stanford.edu

Kentucky Regional Poison Center, Louisville, KY.

BACKGROUND: Atomoxetine uses a novel nonstimulant approach to the treatment of attention deficit hyperactivity disorder. There is limited information on overdose of atomoxetine in children or adults. OBJECTIVE: To provide information on atomoxetine in overdose. METHODS: Case series were conducted at 3 regional poison centers for atomoxetine ingestion in children

[Back To Research Menu]